Crisflash

Crisflash generates short guide RNAs (sgRNAs) and evaluates off-target effects for CRISPR/Cas9 genome editing to enable sgRNA design tailored to any sequenced genome and user-supplied variant data.


Key Features:

  • Flexible Genome Compatibility: Designs sgRNAs against any sequenced genome or set of genome sequences.
  • Incorporation of Variant Data: Integrates user-supplied variant information to tailor sgRNA designs to individual genomes.
  • Rapid Performance: Operates over an order of magnitude faster than comparable sgRNA design tools, including on a single CPU core.
  • Robust Off-Target Scoring: Evaluates potential off-target effects for all candidate CRISPR guide oligonucleotides.

Scientific Applications:

  • Personalized Medicine: Enables sgRNA design tailored to individual genomes for personalized medicine applications.
  • Large-Scale CRISPR Screens: Supports high-throughput sgRNA generation for large-scale CRISPR projects and screens.
  • Functional Genomics: Facilitates guide design and off-target assessment for functional genomics studies.
  • Therapeutic Development: Supports sgRNA development and safety assessment in therapeutic research.
  • Agricultural Biotechnology: Enables design and off-target evaluation for CRISPR applications in agricultural biotechnology.

Methodology:

Uses advanced algorithms to design sgRNAs for high specificity and efficiency, integrates user-supplied variant data into target selection, and applies a robust off-target scoring system to evaluate all candidate guide oligonucleotides.

Topics

Details

License:
GPL-3.0
Maturity:
Mature
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Linux, Mac
Programming Languages:
C
Added:
7/11/2019
Last Updated:
11/24/2024

Operations

Publications

Jacquin ALS, Odom DT, Lukk M. Crisflash: open-source software to generate CRISPR guide RNAs against genomes annotated with individual variation. Bioinformatics. 2019;35(17):3146-3147. doi:10.1093/bioinformatics/btz019. PMID:30649181. PMCID:PMC6735888.

PMID: 30649181
PMCID: PMC6735888
Funding: - Cancer Research UK: 20412, 22398

Documentation

Links